{ "model": { "rank": 9312, "code": "thing-q223911", "model_id": "vr.tr.sarcoma", "name": "sarcoma", "purpose": "Let an agent give general, sourced information about sarcoma, encourage prompt medical review of warning signs, point to specialist centres and support organisations, and avoid personal medical advice or prognosis.", "family": "Thing Registry", "category": "Cross-cutting context", "status": "research-draft", "kind": "thing", "plane": "XCT", "domain": "XCT.STA", "industry": "", "version": "", "url": "/models/thing/q223911/", "tier": 2, "score": 48, "payload": { "layer": "wikidata", "aliases": [ "lipofibromatosis", "myxoid liposarcoma", "fibrosarcoma", "liposarcoma metastatic", "metastatic fibrosarcoma", "metastatic epithelioid sarcoma", "mast cell sarcoma", "liposarcoma", "myxofibrosarcoma", "small cell sarcoma", "epithelioid sarcoma", "myxosarcoma", "ovarian endodermal sinus tumor", "cellular myxoid liposarcoma", "myxoid liposarcoma of the ovary", "desmoplastic small-round-cell tumor", "pseudosarcomatous fibromatosis", "dermatofibrosarcoma protuberans", "fibromatosis", "conventional fibrosarcoma", "pediatric fibrosarcoma", "kidney fibrosarcoma", "breast fibrosarcoma", "heart fibrosarcoma", "central nervous system fibrosarcoma", "small bowel fibrosarcoma", "liver fibrosarcoma", "non-metastatic fibrosarcoma", "ovarian fibrosarcoma", "Giant-cell fibroblastoma", "bone sarcoma", "childhood endodermal sinus tumor", "pediatric liposarcoma", "pediatric epithelioid sarcoma", "central nervous system endodermal sinus tumor", "endodermal sinus tumor", "malignant hemangioma", "malignant skin fibrous histiocytoma", "skin sarcoma", "superficial fibromatosis" ], "aliasCount": 126, "merged": 126, "knownIn": 48, "facets": null, "markers": [], "lexicalClass": "", "senseRank": null, "alsoRegisteredAs": null, "source": { "dataset": "wikidata", "item": "Q223911", "url": "https://www.wikidata.org/wiki/Q223911", "license": "CC0 1.0" } }, "research": { "vercy": "1.0-draft", "publication": { "status": "research-draft", "adjudicationStatus": "unreviewed", "publishableCanonical": false, "generatedAt": "2026-09-11T12:56:33Z", "providers": [ "Claude" ], "breadth": "written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify", "pass": 2, "wave": 1, "engine": "claude" }, "metaModel": { "id": "THING-Q223911", "registryId": "vr.tr.sarcoma", "name": "sarcoma", "version": "0.2.0-wave.1", "entryKind": "thing", "family": "Thing Registry", "domain": [ "XCT.STA" ], "status": "research-draft" }, "canonicalUrl": "https://ver.cy/models/thing/q223911/", "model": { "registry_id": "vr.tr.sarcoma", "name": "sarcoma", "purpose": "Let an agent give general, sourced information about sarcoma, encourage prompt medical review of warning signs, point to specialist centres and support organisations, and avoid personal medical advice or prognosis.", "definition": "A group of rare cancers that arise in connective tissues such as bone, cartilage, fat, muscle, blood vessels and fibrous tissue, divided broadly into soft tissue sarcomas and bone sarcomas, with many subtypes such as liposarcoma, fibrosarcoma and osteosarcoma.", "what_it_is_for": "A group of cancers relevant to diagnosis, specialist care and support.", "affordances": [ "recognise signs that warrant medical review", "find general information on sarcoma types", "find specialist sarcoma centres", "find patient and family support" ], "distinguishing_features": [ "Connective tissue origin", "Rare", "Many subtypes", "Best treated at specialist centres" ], "appearance": "Often a lump or swelling that may grow, or bone pain; diagnosed by imaging and biopsy.", "visual_identification": [ "Lumps that grow or are deep", "Persistent bone pain or swelling", "Carcinomas arise in epithelial tissue" ], "physical_properties": [], "families_and_kinds": [ "soft tissue sarcomas", "bone sarcomas such as osteosarcoma and Ewing sarcoma", "gastrointestinal stromal tumours", "Kaposi sarcoma", "paediatric sarcomas" ], "related_models": [ { "relation": "is a kind of", "target": "cancer", "why": "category" }, { "relation": "arises in", "target": "connective tissue", "why": "tissue" }, { "relation": "is treated at", "target": "specialist sarcoma centre", "why": "care" }, { "relation": "is classified by", "target": "WHO Classification of Tumours", "why": "classification" } ], "identifiers": [], "standards_and_regulation": [ "WHO Classification of Soft Tissue and Bone Tumours", "National suspected cancer referral guidelines", "ESMO sarcoma guidelines" ], "failure_modes_and_hazards": [ "Delayed diagnosis of a growing lump", "Agents giving prognosis or treatment advice", "Unproven alternative treatments" ], "in_scope": [], "out_of_scope": [], "characteristics": [] }, "sources": [], "structure": { "bundles": [ { "id": "signs", "name": "Signs", "description": "When to seek review.", "rationale": "Early review matters.", "layers": [ { "id": "lump", "name": "Lump", "description": "Warning signs.", "findings": [ { "id": "lump-finding", "name": "Lump", "description": "Warning signs.", "questions": [ { "text": "Is there a lump that is growing, larger than a golf ball, deep or painful, or bone pain that persists?", "kind": "boundary" }, { "text": "Should the person book a prompt appointment with a doctor?", "kind": "action" } ] } ] }, { "id": "urgent", "name": "Urgent", "description": "Urgent symptoms.", "findings": [ { "id": "urgent-finding", "name": "Urgent", "description": "Urgent symptoms.", "questions": [ { "text": "Are there severe symptoms such as sudden severe pain or a fracture after minor injury?", "kind": "boundary" }, { "text": "Should urgent medical help be sought now?", "kind": "action" } ] } ] } ] }, { "id": "information", "name": "Information", "description": "General facts.", "rationale": "Sourced information only.", "layers": [ { "id": "types", "name": "Types", "description": "Subtypes.", "findings": [ { "id": "types-finding", "name": "Types", "description": "Subtypes.", "questions": [ { "text": "What do cancer charities or health services say about this sarcoma subtype?", "kind": "provenance" }, { "text": "How is it diagnosed in general terms?", "kind": "definition" } ] } ] }, { "id": "personal", "name": "Personal", "description": "Personal questions.", "findings": [ { "id": "personal-finding", "name": "Personal", "description": "Personal advice limits.", "questions": [ { "text": "Is the user asking about their own diagnosis, treatment or prognosis?", "kind": "boundary" }, { "text": "How should the agent refer them to their specialist team?", "kind": "action" } ] } ] } ] }, { "id": "care", "name": "Care", "description": "Specialist services.", "rationale": "Specialist care matters.", "layers": [ { "id": "centres", "name": "Centres", "description": "Specialist centres.", "findings": [ { "id": "centres-finding", "name": "Centres", "description": "Specialist centres.", "questions": [ { "text": "Which specialist sarcoma centres serve this region?", "kind": "provenance" }, { "text": "How are referrals made?", "kind": "provenance" } ] } ] }, { "id": "trials", "name": "Trials", "description": "Clinical trials.", "findings": [ { "id": "trials-finding", "name": "Trials", "description": "Clinical trials.", "questions": [ { "text": "Which official registries list sarcoma clinical trials?", "kind": "provenance" }, { "text": "Who can discuss eligibility?", "kind": "action" } ] } ] } ] }, { "id": "support", "name": "Support", "description": "Patients and families.", "rationale": "Support helps.", "layers": [ { "id": "charities", "name": "Charities", "description": "Support organisations.", "findings": [ { "id": "charities-finding", "name": "Charities", "description": "Support organisations.", "questions": [ { "text": "Which charities provide sarcoma information and helplines?", "kind": "provenance" }, { "text": "Do they support families and carers?", "kind": "provenance" } ] } ] }, { "id": "distress", "name": "Distress", "description": "Emotional support.", "findings": [ { "id": "distress-finding", "name": "Distress", "description": "Emotional support.", "questions": [ { "text": "Is the person very distressed or in crisis?", "kind": "boundary" }, { "text": "Which crisis line or psychological support service should be offered?", "kind": "action" } ] } ] } ] } ] }, "openQuestions": [ "Should subtypes be separate entries?", "How should specialist centres be linked?", "How should classification updates be tracked?" ], "statistics": { "bundles": 4, "layers": 8, "findings": 8, "questions": 16 } }, "draft": { "generator": "vr.draft.v3", "status": "draft-generated", "researched": false, "archetype": "abstract concept", "method": "Written from the archetype playbook - what this kind of thing needs beyond identity and provenance - and from the structure that recurred across 6,333 models already researched by two engines. Applied to this entry by rule. No source was read for this thing and no claim here is researched. This entry carries no facets of its own, so they were inferred from its domain - a guess about a whole domain applied to one thing.", "facetsInferred": true, "nextPass": "A researcher replaces this draft with a sourced specification. Treat every sentence below as a proposal to argue with.", "purpose": "Give an agent a durable, checkable way to recognise a sarcoma, record what state it is in, and decide what may be done with it.", "whatItIs": "Let an agent give general, sourced information about sarcoma, encourage prompt medical review of warning signs, point to specialist centres and support organisations, and avoid personal medical advice or prognosis.", "characteristics": { "substance": "abstract", "origin": "conceptual", "agency": "inert" }, "whatYouCanDoWithIt": [ "observed and measured" ], "distinguishingFeatures": [ "Names folded into this entry, which a task may need to split apart again: lipofibromatosis, myxoid liposarcoma, fibrosarcoma, liposarcoma metastatic, metastatic fibrosarcoma, metastatic epithelioid sarcoma, mast cell sarcoma, liposarcoma, myxofibrosarcoma, small cell sarcoma, epithelioid sarcoma, myxosarcoma.", "126 finer distinctions are held as aliases rather than separate entries, because telling them apart needs a task that asks for it.", "Described in 48 Wikipedia languages, which is a measure of how widely the thing is known, not of how important it is." ], "openQuestionsForResearch": [ "Which of the bundles below does a real task actually need, and which are ceremony?", "What does this thing have that the facets do not capture at all?", "Which neighbouring kind is most often confused with a sarcoma, and on what evidence are they told apart?" ], "whatItIsMadeOf": "an abstraction with no physical instance", "physicalCharacter": [ "Does nothing on its own; everything it does, something else did to it.", "These come from the domain this entry sits in rather than from the entry itself, so treat them as a first guess about the whole domain applied to one thing." ], "whatCanBeDoneWithIt": [ "observe it, measure it, record its state" ], "howItIsRecognised": [ "Nothing to see. What is recognised is an instance of it, and which instances count is exactly what is argued about." ], "relatedModels": [ { "relation": "covers", "note": "Finer kinds folded into this entry because telling them apart needs a task that asks for it. Each is a model waiting to be split out when one does.", "targets": [ "lipofibromatosis", "myxoid liposarcoma", "fibrosarcoma", "liposarcoma metastatic", "metastatic fibrosarcoma", "metastatic epithelioid sarcoma", "mast cell sarcoma", "liposarcoma", "myxofibrosarcoma", "small cell sarcoma", "epithelioid sarcoma", "myxosarcoma" ] } ], "standing": "Described in 48 Wikipedia languages, which measures how widely it is written about rather than how important or how common it is. 126 finer distinctions are held inside this entry as names rather than as separate models.", "structure": { "bundles": [ { "id": "identity-and-classification", "name": "Identity, naming and classification", "description": "How an agent tells one sarcoma from another, and a sarcoma from things that resemble it.", "rationale": "Recognition comes before every other claim. Without stable identity nothing else in the model can be trusted to be about the same thing twice.", "layers": [ { "id": "naming-and-identifiers", "name": "Names and identifiers", "description": "The names this thing goes by and the identifiers that survive translation and time.", "findings": [ { "id": "preferred-name-and-aliases", "name": "Preferred name, aliases and local names", "description": "Which name to use, which names mean the same thing, and which merely sound similar.", "questions": [ { "id": "preferred-name-and-aliases-q01", "text": "What identifies and describes the name of a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "preferred-name-and-aliases-q02", "text": "Who or what asserted this about the name of a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "preferred-name-and-aliases-q03", "text": "What may an agent decide or do once the name of a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "stable-identifiers", "name": "Stable identifiers and external keys", "description": "Identifiers that keep pointing at this kind of thing across systems and languages.", "questions": [ { "id": "stable-identifiers-q01", "text": "What identifies and describes an identifier for a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stable-identifiers-q02", "text": "Who or what asserted this about an identifier for a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stable-identifiers-q03", "text": "What may an agent decide or do once an identifier for a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "classification-and-granularity", "name": "Classification and granularity", "description": "Where a sarcoma sits among kinds, and how finely a task needs to cut it.", "findings": [ { "id": "kind-and-parents", "name": "Kind, parents and neighbouring kinds", "description": "The classes this thing belongs to and the ones it is next to.", "questions": [ { "id": "kind-and-parents-q01", "text": "What identifies and describes the kind of a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "kind-and-parents-q02", "text": "Who or what asserted this about the kind of a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "kind-and-parents-q03", "text": "What may an agent decide or do once the kind of a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] }, { "id": "distinguishing-features", "name": "Distinguishing features", "description": "What separates a sarcoma from the things most often confused with it.", "questions": [ { "id": "distinguishing-features-q01", "text": "What identifies and describes what distinguishes a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "distinguishing-features-q02", "text": "Who or what asserted this about what distinguishes a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "distinguishing-features-q03", "text": "What may an agent decide or do once what distinguishes a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "state-and-lifecycle", "name": "State and lifecycle", "description": "The states a sarcoma passes through and the events that move it between them.", "rationale": "Most decisions about a thing depend on what state it is in now, which is a claim with a time on it, not a property.", "layers": [ { "id": "lifecycle-stages", "name": "Lifecycle stages", "description": "From coming into existence to ceasing to be one of these.", "findings": [ { "id": "stages-and-transitions", "name": "Stages and transitions", "description": "The stages worth naming and what moves a sarcoma between them.", "questions": [ { "id": "stages-and-transitions-q01", "text": "What identifies and describes the lifecycle of a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "stages-and-transitions-q02", "text": "Who or what asserted this about the lifecycle of a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "stages-and-transitions-q03", "text": "What may an agent decide or do once the lifecycle of a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "observations-and-status", "name": "Observations and current status", "description": "What is observed about a sarcoma, how often and by whom.", "findings": [ { "id": "observation-record", "name": "Observation record", "description": "How an observation of a sarcoma is recorded so that it can be superseded rather than overwritten.", "questions": [ { "id": "observation-record-q01", "text": "What identifies and describes an observation of a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "observation-record-q02", "text": "Who or what asserted this about an observation of a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "observation-record-q03", "text": "What may an agent decide or do once an observation of a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] }, { "id": "definitions-in-contest", "name": "Definitions and who holds them", "description": "What sarcoma is taken to mean, and by whom.", "rationale": "When a field disagrees about a concept, the disagreement is the content. A model that picks one definition silently destroys the information.", "layers": [ { "id": "competing-definitions", "name": "Competing definitions", "description": "The main readings and the traditions behind them.", "findings": [ { "id": "definition-map", "name": "Definitions and their holders", "description": "Each definition with the school or body that holds it.", "questions": [ { "id": "definition-map-q01", "text": "Which definitions of sarcoma are in use, and which tradition or body holds each?", "kind": "definition" }, { "id": "definition-map-q02", "text": "What turns on the difference between them in practice?", "kind": "boundary" } ] } ] }, { "id": "operationalisation", "name": "Operationalisation", "description": "How it is measured or applied when it has to be.", "findings": [ { "id": "operational-record", "name": "Measures and proxies", "description": "Instruments and indicators used to stand in for it.", "questions": [ { "id": "operational-record-q01", "text": "How is sarcoma operationalised or measured in practice, and by what instrument?", "kind": "measurement" }, { "id": "operational-record-q02", "text": "What does that operationalisation leave out, and when does that matter?", "kind": "boundary" } ] } ] } ] }, { "id": "instances-and-use", "name": "Instances, use and consequence", "description": "What counts as an instance of sarcoma and what follows from calling something that.", "rationale": "Applying a concept is an act with consequences, so a model must say what the label licenses and what it does not.", "layers": [ { "id": "instances", "name": "What counts as an instance", "description": "Clear cases, borderline cases and non-cases.", "findings": [ { "id": "instance-tests", "name": "Tests for an instance", "description": "What would settle whether something falls under it.", "questions": [ { "id": "instance-tests-q01", "text": "What would settle whether something is an instance of sarcoma?", "kind": "boundary" }, { "id": "instance-tests-q02", "text": "Which borderline cases are argued about, and on what grounds?", "kind": "definition" } ] } ] }, { "id": "consequence", "name": "Consequence of application", "description": "Rights, duties or decisions that follow from the label.", "findings": [ { "id": "consequence-record", "name": "What the label licenses", "description": "What an agent may do once something is classified this way.", "questions": [ { "id": "consequence-record-q01", "text": "What follows practically once something is treated as sarcoma?", "kind": "action" }, { "id": "consequence-record-q02", "text": "What must an agent not infer from the label alone?", "kind": "action" } ] } ] } ] }, { "id": "provenance-and-evidence", "name": "Provenance, evidence and time", "description": "Where every claim about a sarcoma came from and when it held.", "rationale": "A claim without a source and a time cannot be superseded, only overwritten, and an agent that overwrites loses the ability to explain itself.", "layers": [ { "id": "source-and-authority", "name": "Source and authority", "description": "Who said it, on what evidence, and how strongly.", "findings": [ { "id": "claim-provenance", "name": "Claim provenance and confidence", "description": "The authority behind each claim about a sarcoma and how confident it is.", "questions": [ { "id": "claim-provenance-q01", "text": "What identifies and describes a claim about a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "claim-provenance-q02", "text": "Who or what asserted this about a claim about a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "claim-provenance-q03", "text": "What may an agent decide or do once a claim about a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] }, { "id": "time-and-versions", "name": "Time, versions and supersession", "description": "When a claim was true, when it was learnt, and what replaced it.", "findings": [ { "id": "validity-and-supersession", "name": "Validity period and supersession", "description": "How an old claim about a sarcoma is retired without being erased.", "questions": [ { "id": "validity-and-supersession-q01", "text": "What identifies and describes the validity of a claim about a sarcoma, and in what units or vocabulary?", "kind": "definition", "answer_data": [ "identifiers", "types and classes", "values with units", "explicit unknowns" ] }, { "id": "validity-and-supersession-q02", "text": "Who or what asserted this about the validity of a claim about a sarcoma, by which method, and when was it true?", "kind": "provenance", "answer_data": [ "authority", "method", "evidence", "event time", "knowledge time" ] }, { "id": "validity-and-supersession-q03", "text": "What may an agent decide or do once the validity of a claim about a sarcoma is known, and what must it refuse?", "kind": "action", "answer_data": [ "permitted actions", "preconditions", "refusals", "escalation" ] } ] } ] } ] } ] }, "statistics": { "bundles": 5, "layers": 10, "findings": 12, "questions": 32 } } } }